Importantly, mast cell‐derived IL‐6 has been implicated in a variety of pathological contexts, including atherosclerosis 23, stroke pathology 24, arthritis 25, Th17 skewing 26, mastocytosis 27, and diabetes 28. Here, IL6 is linked to mastocytosis.